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Stac3 is a component of the excitation–contraction
coupling machinery and mutated in Native
American myopathy
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Excitation–contraction coupling, the process that regulates contractions by skeletal muscles,
transduces changes in membrane voltage by activating release of Ca2þ from internal stores
to initiate muscle contraction. Defects in excitation–contraction coupling are associated with
muscle diseases. Here we identify Stac3 as a novel component of the excitation–contraction
coupling machinery. Using a zebrafish genetic screen, we generate a locomotor mutation that
is mapped to stac3. We provide electrophysiological, Ca2þ imaging, immunocytochemical
and biochemical evidence that Stac3 participates in excitation–contraction coupling in
muscles. Furthermore, we reveal that a mutation in human STAC3 is the genetic basis of the
debilitating Native American myopathy (NAM). Analysis of NAM stac3 in zebrafish shows
that the NAM mutation decreases excitation–contraction coupling. These findings enhance
our understanding of both excitation–contraction coupling and the pathology of myopathies.
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M
uscle contractions are initiated by depolarization of the
voltage across the plasma membrane resulting from
synaptic release at the neuromuscular junction (NMJ).
Excitation–contraction (EC) coupling is responsible for transdu-
cing the shift in the membrane voltage to increase cytosolic levels
of Ca2þ that leads to contraction. Genetic defects in EC coupling
components are associated with numerous congenital myopa-
thies1 that appear in infancy and are characterized by a variety of
symptoms that include muscle weakness, difficulty with breathing
and feeding, slower development, muscle cramps, stiffness and
spasm, and in some cases susceptibility to malignant
hyperthermia, which is an adverse reaction to general
anaesthesia that can be fatal. Despite the debilitating nature of
congenital myopathies, their pathology is for the most part poorly
understood. Congenital myopathies are highly heterogenous, and
the genetic basis of many disorders are unknown.
In skeletal muscles, EC coupling occurs at triads. Triads are
junctions of the transverse tubules that are infoldings of the
sarcomembrane and the sarcoplasmic reticulum (SR), an internal
Ca2þ store. Changes in the membrane voltage of the transverse
tubules are detected by the dihydropyridine receptor (DHPR), an
L-type Ca2þ channel located in the transverse tubule membrane
at triads2–5. DHPR is composed of the principal a1s subunit also
called CaV1.1 that contains the pore and several accessory
subunits. Activated DHPR, in turn, is thought to directly activate
ryanodine receptor 1 (RyR1) Ca2þ release channels in the SR
membrane side of the triadic junctions6–9. In mammalian skeletal
muscles, the DHPR also conducts extracellular Ca2þ to the
cytosol but this is not required for EC coupling10. Interestingly, in
teleost skeletal muscles EC coupling is similarly independent of
Ca2þ influx from the exterior and the DHPR appears to have
evolved so that it no longer conducts Ca2þ (ref. 11). Activation of
RyR1 leads to release of Ca2þ from the SR to the cytosol and
subsequently to contraction mediated by the contractile
machinery.
EC coupling involves a complex of proteins localized to triads
that include DHPR and RyR1. Although DHPR and RyR1 are
well studied, the identity and roles of other components of the
complex, how EC coupling is regulated and how the triadic
molecular complex is established are poorly understood. Some of
the other components of the triadic complex include FKBP12,
triadin, junctin and calsequestrin. Triadin, junctin and calseques-
trin are SR proteins that regulate RyR1 from the luminal side of
SR12–14. FKBP12 is an immunophilin, an immunosuppressive
drug-binding protein, that copurifies and co-immunoprecipitates
with RyR1 in striated muscles15, and stabilize RyRs in their open
state in vitro16. Two other cytosolic proteins that interact with EC
components are SepN1 and calmodulin (CaM). SepN1 is a
selenoprotein that co-immunoprecipitates with RyR1a and is
associated with myopathy17 and is required for formation of slow
twitch muscles in zebrafish18. CaM can bind RyR and DHPR, and
modify EC coupling19. Despite the identification of these factors,
the mechanisms for how they regulate EC coupling is poorly
understood. These analyses illustrate the complexity of the EC
coupling complex and its regulation, and suggest that a forward
genetic strategy might be useful for identification of novel
components for EC coupling.
Zebrafish have been useful for the analysis of a myriad of
biological processes both because they are amenable to forward
genetic screens and in vivo manipulations20,21. Pertinent to a
genetic analysis of EC coupling, zebrafish muscles can also be
analysed in vivo with electrophysiology and live imaging22,23. We
took advantage of these features to identify a zebrafish mutation
in which EC coupling was defective. The gene responsible for the
mutant phenotype encoded for Stac3, a putative muscle-specific
adaptor protein. Finally, we found that a missense mutation in
human STAC3 is responsible for the debilitating, congenital
Native American myopathy (NAM)24,25.
Results
The mi34 zebrafish mutant is defective in EC coupling. To
identify new genes involved in the regulation of EC coupling, a
forward genetic screen in the zebrafish was performed to
isolate motor behaviour mutants26–30. One mutation, mi34, was
autosomal recessive with mutants dying as larvae and exhibiting
defective motor behaviours at early stages of development.
Normally zebrafish embryos exhibited spontaneous slow coiling
of the body starting at 17 h post fertilization (hpf), touch-induced
escape contractions of the body at 22 hpf and touch-induced
swimming by 28 hpf (ref. 31). Mutants were defective in all three
motor behaviours with reduced amplitude of spontaneous coiling,
decreased touch-induced escape contractions and ineffective
swimming (Supplementary Movies S1–6; Fig. 1a).
Aberrant behaviour in mutants could be due to defects in the
nervous system and/or skeletal muscles. If signalling within the
nervous system were abnormal in mutants, then one would
expect the output of motor neurons to muscles to be aberrant. To
determine this, the synaptic response of muscles to tactile
stimulation of the embryo was electrophysiologically recorded
in vivo. Tactile stimulation initiated synaptic responses in both
slow and fast twitch muscles in both wild-type (wt) sibling and
mutant embryos. The evoked responses were comparable in
amplitude, duration and frequency, when measured with a low
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Figure 1 | mi34 mutant zebrafish exhibit defective swimming but CNS output is normal. (a) Touch evoked swimming in wt but not stac3mi34 embryos
(48 hpf). Panels show superimposed frames (30Hz) of swimming motion from wt sibling and stac3mi34 embryos with heads embedded in agar. (b) Voltage
recordings with 6-mM curare showing that touch-evoked synaptic responses of slow twitch (wt sib: n¼ 5; mut: n¼6) and fast twitch muscles (wt
sib: n¼ 6; mut: n¼4) of wt sibling and stac3mi34 mutants (48 hpf) are comparable. (c) Voltage recordings with no curare showing that mutant fast twitch
muscles (48 hpf) respond to tactile stimulation with a burst of action potentials (n¼ 8).
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concentration of curare (see Methods) used to minimize muscle
contraction (Fig. 1b; Supplementary Fig. S1). To see if the mutant
muscles would generate action potentials in response to synaptic
input, we examine muscle responses following sensory stimula-
tion without curare, which was possible because contraction by
mutant muscles is minimal. These recordings showed that mutant
fast twitch muscles do respond with a burst of overshooting
action potentials (Fig. 1c). Furthermore, there were no obvious
differences in the distribution of motor neuron terminals and
muscle acetylcholine receptors (AChRs) between wt sibs and
mutants when assayed with an antibody against SV2, a synaptic
vesicle protein, and a-bungarotoxin that specifically binds AChRs
(Supplementary Fig. S2). Thus, the nervous system and NMJ
between wt and mutants is comparable and mutant muscles can
initiate bursts of action potentials in response to synaptic input.
Although we cannot rule of subtle changes, the severity of the
behavioural phenotype is consistent with the mutation causing a
defect in the muscle response to electrophysiological activation.
Activation of the NMJ leads to depolarization of the muscle
membrane potential that in turn initiates muscle contraction. To
examine how the mutation affects the relationship between
muscle voltage and contraction, the membrane voltage of skeletal
muscles was depolarized to various values and the amount
muscles contracted was measured. Mutant muscles contracted
much less than wt sib muscles at depolarized membrane
potentials (Supplementary Fig. S3). The decreased contraction
to depolarizations could be due to a defect in EC coupling or a
defect in the contractile machinery. However, the fact that mutant
and wt sib muscles contracted similarly when exposed to caffeine,
an agonist of RyRs, (Supplementary Fig. S4) suggested that the
contractile machinery was intact in mutants and that the store of
Ca2þ in the SR was not grossly perturbed. Corroborating this
finding, mutant muscles exhibited no obvious morphological
defects early in the development with apparent normal distribu-
tion of contractile proteins and other muscle proteins
(Supplementary Fig. S4). Furthermore, myofibers appeared
normal in electron micrographs of larval skeletal muscles in
mi34 mutants (Fig. 2a). These findings pointed to a defect in EC
coupling in mutant muscles.
The hallmark of EC coupling is the release of Ca2þ from the
SR to the cytosol. EC coupling was directly examined in vivo by
imaging Ca2þ transients in skeletal myofibers, expressing the
GCaMP3 Ca2þ indicator32 during swimming. Swimming was
evoked by application of NMDA, which activated the swimming
network in the central nervous system28. Ca2þ transients were
greatly reduced in both mutant slow and fast twitch fibres
(Fig. 2b,c). Thus, EC coupling in skeletal muscles was defective in
the mi34 mutants. As EC coupling takes place at triads, reduced
EC coupling in mutants could be due to abnormal formation of
triads. However, longitudinal sections examined with
transmission electron microscopy showed that there were triads
at every intermyofibrillar junction with triads exhibiting
comparable anatomy including two rows of feet in wt sib and
mutant muscles (Fig. 2a). Although we cannot rule out a
quantitative change in triadic anatomy, these data showed that
the decrease in EC coupling in mutant muscles was not due to
any obvious defect in triad anatomy.
stac3 is the basis for the mi34 phenotype. A combination of
meiotic mapping and analysis of zebrafish genome resources
identified the gene responsible for the mi34 phenotype as stac3
(Supplementary Fig. S5; for details see Methods), a gene similar to
murine stac that encodes an adaptor-like protein of unknown
function33. stac3 encodes for a putative 334 residue soluble
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Figure 2 | EC coupling is defective in mi34 mutant zebrafish embryos. Electron micrographs showing that the ultrastructure of myofibrils and triadic
junctions are comparable between the muscles of 4 days post fertilization (dpf) wt sibling (a, left) and mi34 mutants (a, right). Top: longitudinal sections
showing several myofibrils and triads sectioned at right angle to the T tubule long axis. Scale: 500nm. Bottom: at left a section tangent to the triad, showing
one of the two long rows of feet (RyR) that occupy the junctional gap. Scale: 250 nm. Bottom: at right a section transverse to the triad axis showing
two feet (arrowheads) in the junctional gap of the triad. Scale: 100 nm. (b) Ca2þ transients recorded from GCaMP3-expressing fast and slow twitch fibres
are significantly decreased and slower in 48 hpf stac3mi34 mutants. (c) Left: quantification of peak Ca2þ release with black and grey bars representing wt
sib (fast, n¼ 5; slow, n¼ 5) and stac3mi34 (fast, n¼ 9; slow, n¼ 7) fibres, respectively. #Denotes that peak Ca2þ was 0. Right: quantification of Ca2þ
transient kinetics in fast fibres with black and grey bars representing wt sib and stac3mi34, respectively. Half width denotes the duration the transient is
450% of peak value. Error bars represent s.e.m.’s. Asterisks signifies Po0.01, t-test.
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to the C1 domain found in Ca-dependent protein kinase and two
SH3 domains (Fig. 3a). The mutant allele carried a point
mutation that disrupted a splice donor site that led to the
inclusion of intron 4 and a premature stop codon in the
transcript. The mutation in stac3 predicted a protein that was
truncated within the N-terminal CRD, suggesting that the
stac3mi34 mutation was functionally null. Western blotting with
an antibody generated against Stac3 that recognized a fragment of
Stac3 consisting of the residues 1–63 (see Methods) revealed an
B49 kDa protein in wt embryos but no protein in mutants
(Fig. 3b), suggesting that a truncated protein was not synthesized
in mutants. In situ hybridization showed that skeletal muscles
selectively expressed stac3 during embryogenesis (Supplementary
Fig. S6). Labelling with anti-Stac3 confirmed that Stac3 was
specifically expressed by skeletal muscles and revealed that Stac3
co-localized with the DHPRa1 and presumably RyR1 at muscle
triads in wt but was not expressed in mutant embryos (Fig. 3c).
These findings suggested that a mutation in stac3 was responsible
for defective EC coupling and that Stac3 was a component of the
triadic molecular complex.
The molecular identity of the mutation was confirmed by
mutant rescue experiments. Induced expression of hsp70:stac3wt-
egfp in mutant muscles rescued the behavioural phenotype and
triadic localization of Stac3, whereas induced expression of
hsp70:stac3mi34-egfp did not (Fig. 4a). Furthermore, Ca2þ
imaging of mutant muscles coexpressing stac3wt-mCherry and
GCaMP3 showed that wt Stac3 could restore Ca2þ muscle
transients in mutant embryos (Fig. 4b,c). Given that Stac3 may be
an adaptor protein and co-localizes with DHPRa1 and RyR1, we
examined whether Stac3 may be part of the triadic molecular
complex. Indeed co-immunoprecipations with antibodies against
pan-RyR and DHPRa1 both pulled down Stac3 from wt adult
muscles (Fig. 5), indicating that Stac3 is part of the DHPR/RyR1
complex found at triads. This was confirmed by generating a
transgenic line of zebrafish (a-actin:stac3wt-egfp) that expressed
Stac3-EGFP in the skeletal muscles and by using anti-GFP to
immunoprecipitate Stac3-EGFP from lysates of skeletal muscle of
adult transgenic zebrafish. Mass spectrometry-based protein
identification found that DHPRa1s, DHPRa2d1, DHPRb1, RyR1
and RyR3 immunoprecipitated with Stac3-EGFP (Supplementary
Table S1). Thus, Stac3 is a component of the triadic complex that
is required for EC coupling in skeletal muscles.
Although motor behaviours are greatly diminished in stac3mi34
mutants, they were not immotile. One possible reason for this
might be the existence and action of Stac3 derived from
maternally deposited stac3 mRNA. In fact, RT-PCR (PCR with
reverse transcription) from 2hpf embryos (before zygotic
expression34) found that stac3 was maternally expressed
(Fig. 6a). To see whether the residual activity of skeletal
muscles in stac3mi34 mutants was due to Stac3 translated from
maternal mRNA, we knocked down Stac3 by injecting a
translation-blocking antisense Morpholino oligonucleotide
(MO) against stac3 message into embryos from crosses between
heterozygous carriers. Anti-Stac3 labelling showed that stac3
antisense MO-injected embryos did not express Stac3 in the
skeletal muscles (Fig. 6b), confirming that the MO was effective.
At 48 hpf wt embryos normally respond to tactile stimulation by
swimming away. As expected from a cross between heterozygous
carriers B75% of the progeny injected with control MO
responded to touch with swimming whereas 25% responded by
slight muscle contractions (shivering) that failed to move the
embryos effectively or were totally immotile (Fig. 6c), indicative
of the mutant phenotype. In antisense MO-injected embryos,
however, there was a significant increase in embryos that were
either immotile or shivered and decrease in embryos that swam
compared with control progeny. Significantly the proportion of
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Figure 3 | The muscle-specific gene stac3 underlies the mi34 phenotype. (a) Diagram of the predicted wt Stac3 protein (top). Arrow denotes location of
the stop codon. DNA sequence of corresponding regions of wt cDNA, wt genomic DNA and stac3mi34 cDNA showing that a missense mutation in a
splice donor site lead to the inclusion of the intron (bracket) and stop codon (asterisk) in the mutant cDNA. (b) Stac3 protein appears not to be
synthesized in mutants. Western blot of showing that anti-Stac3 labels a band from wt but not mutant embryos at 48 hpf. b-Actin was the loading control.
(c) Stac3 co-localizes with RyR and DHPRa1 in the skeletal muscles. Left, side view of the trunk of 48 hpf embryos labelled with anti-Stac3 showing that
both fast twitch and slow twitch express Stac3 in wt but not mutant embryos. Scale: 60mm. Inset shows the brightfield image of the trunk of the mutant.
Right, dissociated 48 hpf wt muscle fibres labelled with anti-Stac3 and anti-RyR or anti-DHPRa1 showing that Stac3 co-localizes with RyR and DHPRa1.
Scale: 10mm.
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immotile embryos increased from B5% of control MO-injected
progeny to almost 40% of antisense MO-injected progeny.
Furthermore, the morphant phenotype was rescued by
coinjecting an expression plasmid for stac3wt along with the
antisense MO, demonstrating that the increased defective motility
observed was not due to an off-target effect of the antisense MO,
but rather a specific knockdown of maternal stac3. This suggests
that elimination of both maternal and zygotic Stac3 results in
immotility.
A mutation in human STAC3 causes a congenital myopathy.
The loss of Stac3 resulted in a progressive breakdown of myofi-
bers during larval stages with apparent swollen SR observed by
7 days post fertilization (Supplementary Fig. S7). Given the
myopathic features of mutants, we explored whether stac3
mutations might cause congenital human myopathies. Human
STAC3 mapped to chromosome 12q13-14, and its specific loca-
tion was within the previously defined genetic locus for the
congenital NAM (refs 24,25). NAM is an autosomal recessive
disorder found within the Lumbee Native American population
of North Carolina that was characterized by a constellation of
clinical features, including congenital onset of muscle weakness,
susceptibility to malignant hyperthermia, multiple joint contractures
and dysmorphic facial features including ptosis. Patient muscle















































































Figure 4 | Expression of wt Stac3 in muscles rescues the stac3mi34 phenotype. (a) Left, histogram showing that mutant embryos expressing heat-
inducible stac3wt-egfp (black, n¼ 32) but not stac3mi34-egfp (light grey, n¼4) nor uninjected mutant embryos (dark grey, n¼ 10) exhibited touch-evoked
swimming at both 3 h post heat shock (hphs) and 24 hphs. #Denotes no swimming. Right panels, superimposed frames (30Hz, 1 s) (top) show that mutant
embryos expressing stac3wt but not stac3mi34 swim in response to touch, although both are similarly expressed by muscles (middle, scale: 180mm). In
dissociated mutant muscles Stac3wt-EGFP localizes to the triads but not Stac3mi34-EGFP (bottom, scale: 10mm). (b) In vivo expression of Stac3wt-mCherry
by mutant muscle fibres rescues Ca2þ transients. Left panels, stac3mi34 mutant slow and fast twitch fibres coexpressing a-actin-driven GCaMP3 and heat-
induced Stac3wt-mCherry. The triadic localization of Stac3wt-mCherry cannot be seen due to the low resolution of the resonance scans used to detect the
fluorescent proteins. (c) Top, Ca2þ transients from mutant fast and slow fibres coexpressing Stac3wt-mCherry and GCaMP3. Middle, histogram showing
that peak Ca2þ release is comparable between wt (black) fast (n¼ 5) and slow (n¼ 5) fibres, and rescued mutant (grey) fast (n¼6) and slow (n¼ 2)





































































Figure 5 | Stac3 forms a molecular complex with DHPR and RyR. (a)
Immunoblots (IB) showing that immunoprecipitation (IP) with anti-DHPRa1
but not mouse IgG pulls down DHPRa1 and Stac3 from adult skeletal muscle
lysate (n¼ 3). Skeletal muscle lysate lane is a immunoblot showing Stac3
and DHPRa1 are expressed by muscles. (b) Immunoblots showing that
immunoprecipitation with anti-pan-RyR but not mouse IgG pulls down RyR
and Stac3 from adult skeletal muscle lysate (n¼ 3). Skeletal muscle lysate
lane is a immunoblot, showing Stac3 and RyR are expressed by the muscles.
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36% of afflicted individuals die by the age of 18. The genetic basis of
NAM remained unsolved, though the presence of susceptibility to
malignant hyperthermia as a clinical feature suggested a defect in a
component of the EC coupling apparatus. To see whether a
mutation in STAC3 was the basis for NAM, STAC3-coding regions
were sequenced in a cohort of five NAM families that included 5
affected and 13 unaffected individuals. As expected for an autosomal
recessive disorder, all affected individuals were homozygous for a
G4C missense mutation of base pair 1,046 in exon 10 of the STAC3
gene (Ensembl transcript ID ENST00000332782), while all obligate
carriers were heterozygous. This mutation resulted in a tryptophan
(W) to serine (S) substitution at amino acid 284 in the first SH3
domain (Fig. 7). The sequence change perfectly segregated with the
NAM phenotype, and was neither found in an additional three
unaffected, unrelated Lumbee individuals (Supplementary Fig. S8),
nor in 113 Caucasian control individuals. In addition, STAC3 has
been sequenced as part of the 1,000 genome project, and this
mutation has not been detected. This pattern of inheritance
suggested that STAC3 was the basis for the congenital myopathy.
Next the functional consequences of the W284S mutation was
investigated in the zebrafish model system. The analogous W4S
substitution was encoded in zebrafish stac3 (hsp70:stac3NAM-egfp)
and expressed in stac3mi34-null mutant muscles to assay for
phenotypic rescue. Unlike stac3wt-egfp, expression of stac3NAM-
egfp failed to rescue touch-induced swimming, although some
Stac3NAM localized to triads (Fig. 8a). Furthermore, Ca2þ
imaging of mutant fast but not slow twitch muscles expressing
stac3NAM-mCherry and GCaMP3 exhibited Ca2þ transients that
were decreased compared with mutant muscles expressing
stac3wt-mCherry and GCaMP3 (Figs 4b and 8b,c). Presumably
the mosaic expression of a partially effective allele was insufficient
to result in behavioural rescue. Decreased Ca2þ transients in fast
twitch but not slow twitch muscles expressing stac3NAM predicts
defective swimming, as by 48 hpf swimming is dependent on fast
twitch muscle contractions and independent of slow twitch
contractions35. Additionally, expression of wt human STAC3 in
mutant zebrafish muscles rescued the motor phenotype
(Supplementary Fig. S9). Thus, the NAM mutation appeared to
diminish EC coupling in fast twitch muscles and was causative for
the congenital myopathy.
Discussion
This study identified Stac3 as a novel component of EC coupling
in skeletal muscles, and a mutation in STAC3 as the cause for
NAM. A recent study suggested that MO-mediated knockdown
of stac3 in zebrafish embryos resulted in defective myofibrillar
formation in skeletal muscles36, but we found that myofibrils in
embryonic and larval zebrafish were comparable between wt sibs
and stac3mutants. This discrepancy might be due to the maternal
wt stac3 transcript found in stac3 nulls, which could have been
sufficient for normal myofibrillar formation in mutants.
In principle, Stac3 could participate in EC coupling via a
variety of mechanisms. One possibility is that Stac3 might
modulate the channel properties of DHPR and/or RyR1. The
triadic localization of Stac3 and biochemical demonstration that
Stac3 is part of the DHPR/RyR1 complex are consistent with this
possibility. Regulation of DHPR or RyR1 channel properties by
other triadic components include modulation of the properties of
DHPR by RyR1 and of RyR1 by FKBP12. In murine RyR1-
deficient myotubes, the complement of DHPR on the muscle
membrane is normal, but the DHPRs pass much less Ca2þ than
normal37. The immunophilin, FKBP12, copurifies with RyR, and
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Figure 6 | stac3 mRNA is maternally expressed. (a) RT-PCR from 2 and 3 hpf embryos showing that stac3 mRNA is maternally expressed. Midblastula
transition starts at 3 hpf. stac3 mRNA is not expressed in the adult brain. tuba1, a house-keeping gene that is maternally expressed, serves as a
positive control and stac3 in the adult brain as a negative control. stac3 50 and 30 refer to primers used for amplifying either 50 or 30 fragments of stac3 from
stac3 cDNA (see Methods). (b) Micrographs showing anti-Stac3 labelled embryos (48 hpf) that had been injected with stac3 antisense MO (top) but not
control MO (bottom) exhibit little to no Stac3. Muscle nuclei are labelled with 40 ,6-diamidino-2-phenylindole (DAPI; blue). Scale: 5 mm. (c) Knocking down
Stac3 in 48 hpf embryos significantly increases the proportion of progeny from a cross between stac3mi34 heterozygous carriers that are immotile or shiver
and decreases those that swim in response to touch. *Denotes that the percentage of stac3 MO-injected progeny that were immotile or shivered was
greater than control MO-injected progeny (respectively, Po0.001 and Po0.01; t-test); percentage of stac3 MO-injected progeny that swam was less than
control MO-injected progeny (Po0.001, t-test). **Denotes that coinjection of an expression plasmid for stac3wt with stac3 antisense MO decreases
immotility and restores swimming in a great majority of progeny. Percentage of stac3 MOþ expression plasmid for stac3wt-injected progeny that were
immotile was much less than stac3 MO alone progeny (Po0.001, t-test). Error bars represent s.e.m.’s.
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RyRs were examined with single channel recordings, FKBP12 was
found to optimize channel function15. The b-subunits of voltage-
dependent Ca channels are also known to regulate properties of a
variety of Ca channels38. It is possible that Stac3 could interact
with the b1a-subunit to regulate DHPR channel properties in the
skeletal muscles.
Another possibility is that Stac3 may regulate the precise
organization of DHPRs and RyR1s at triadic junctions of the
t-tubules and SR. At triads, DHPRs and RyR1s are organized in a
precise manner with DHPRs arranged in geometrically arranged
groups of four called tetrads, with each tetrad apposed to every
other RyR1 homotetramer39. The b1a-subunit of DHPR also
appears to be critical for this, as b1a is required for the formation
of DHPRs into tetrads23.
Stac3 might also regulate the amount of DHPR and/or RyR1 at
triads, perhaps by modulating protein trafficking and/or stability
of DHPR and/or RyR1. An example of a factor that may be
important for trafficking or stability of DHPRs is REM, a member
of the RGK GTP-binding protein family. REM can bind
b-subunits of voltage-dependent Ca2þ channels, when expressed
heterologously, and overexpression of REM inhibits L-type Ca2þ
channels in C2C12 cells40 and skeletal muscles due to a decrease
of DHPR in the muscle membrane41 via dynamin-dependent
endocytosis42. Although the loss-of-function phenotype for REM
is not known, these results suggest that REM inhibits localization
of DHPRs in triads either by decreasing processing of the
channels into triadic junctions or by increasing the removal of the
channel from triads. Interestingly the DHPRb1 subunit regulates
the levels of plasma membrane DHPRa1c (CaV1.2) that is
expressed by cardiac muscle cells and neurons by inhibiting the
degradation of these channels via endoplasmic reticulum-
associated protein degradation43. Examination of the amount of
DHPR and RyR1 at triads in stac3 mutants versus wt muscles
should clarify whether Stac3 controls the levels of these key
components in skeletal muscles. Furthermore, it should be
possible to investigate whether Stac3 regulates protein
trafficking of key components of EC coupling using various
transgenics combined with live-imaging strategies in zebrafish to
directly examine fluorescently labelled EC components, as they
are trafficked from the ER to triads and are endocytotically
removed from the triads. Furthermore, the availability of mutants
deficient for DHPR (refs 23,29) and RyR1 (ref. 30), in addition to
the stac3mi34 mutant, should be invaluable for mechanistic
analysis of Stac3 for EC coupling.
The NAM mutation converted W284 to S in the first SH3
domain of Stac3. Interestingly, an analysis of binding specificities
of SH3 domains using a generic structure-based model found that
this W, which is in the loop region of the SH3 domain and is
highly conserved across SH3 domains, is one of the most
important residues for binding specificity44. Our finding that
expression of Stac3NAM in Stac3-null zebrafish leads to decreased
EC coupling suggests that interactions of the first SH3 domain in
Stac3 is important for normal EC coupling. In fact, components
of the triadic molecular complex including DHPRa1s, DHPRb1a
and RyR1 contain numerous SH3-binding sequences in their
predicted cytoplasmic portions. Thus, it would be interesting to
see whether Stac3 might interact with triadic components such as
DHPR and/or RyR1 via the Stac3 SH3 domain and whether such
an interaction is necessary for normal EC coupling. Interestingly,
the structure-based model also identified three other residues
found in human Stac3 (Y255, E283 and N299) that also
significantly affected binding specificity44. The roles of these
residues for EC coupling could be examined by expressing
appropriately mutagenized Stac3 in the zebrafish stac3 nulls.
Genetic and physiological approaches should also be useful for
the generation of transgenic lines of stac3NAM mutant zebrafish to
delineate the pathology of NAM and for identifying potential
therapeutic agents. This is particularly relevant, given the
increasing recognition of mutations in genes associated with EC
coupling in a growing range of human muscle diseases. In
addition, STAC3 is an attractive candidate for the genetic basis of
currently undefined congenital myopathies, particularly those
associated with susceptibility to malignant hyperthermia and/or
those with phenotypes similar to those of patients with RYR1 or
DHPR mutations.
Methods
Animals and behavioural analysis. Zebrafish were bred and maintained
according to approved guidelines of the University Committee on Use and Care of
Animals at the University of Michigan. The stac3mi34 mutation was isolated from a
mutagenesis screen using procedures previously reported19,20. Embryonic
behaviours were video recorded with a CCD camera mounted on a
stereomicroscope and analysed with ImageJ. In some cases, the heads of embryos
were embedded in low melting temperature agar with the trunk and tail free to
move. Where indicated data were analysed by t-tests.
Electrophysiology. Previously published protocols were followed to electro-
physiologically record from zebrafish embryonic muscles21. For recordings
embryos were partially curarized (6mM d-tubocurarine). Recordings of muscle
responses to touch were made with patch electrodes (3–10MO) filled with solution
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Figure 7 | Missense mutation in human STAC3 causes NAM. Left top,
sequence chromatographs of corresponding exonic region of the STAC3
gene of individuals that were þ /þ , þ / and  / for the NAM locus
showing the G4C missense mutation in the stac3 gene. N denotes the G/C
heterozygous nucleotide. Right top, pedigree of an individual exhibiting
NAM (black) and homozygous for the missense mutation (C/C).
Unaffected parents were carriers for the mutation (G/C) and the
unaffected sibling was homozygous for the wt nucleotide (G/G). Middle,
alignment of the corresponding region of Stac3 containing NAM mutation
showing that the missense mutation results in a W4S substitution in NAM
individuals and that this W is completely conserved between various
mammals and zebrafish. Bottom, diagram showing that the missense
mutation in Stac3NAM is located in a SH3 domain.
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EGTA and 4mM Na3ATP at 273mOsm and pH 7.2 and extracellular Evans
solution (134mM NaCl, 2.9mM KCl, 2.1mM CaCl2, 1.2mM MgCl2, 10mM
glucose and 10mM Hepes at 290mOsm and pH 7.8) using an Axopatch 200B
amplifier (Axon Instruments), low-pass filtered at 5 kHz and sampled at 1 kHz.
Mechanosensory stimulation was delivered by ejecting bath solution from a pipette
using a Picospritzer. Voltage dependence of contraction was performed in a similar
manner except embryos were exposed to 50 mM d-tubocurarine, voltage steps
delivered to muscle via voltage clamp and muscle contractions video recorded at
60Hz. Muscle contractions to caffeine applied by a Picospritzer (10 psi, 1 s) of
dissected embryos were video recorded and measured.
Ca2þ imaging. One-cell stage embryos were injected with a plasmid using a-actin
promoter29 (a-actin:GCaMP3) resulting in embryos that mosaically expressed
a-actin:GCaMP3 within skeletal muscle. Forty-eight hours post fertilization
embryos were genotyped by behaviour. Before imaging, tricaine was removed and
embryos allowed to recover in Evans for 10min and treated with 200 mM
N-benzyl-p-toluene sulphonamide to inhibit contraction for 5min. Hundred
micromolar NMDA was added to initiate the swimming motor network17.
GCaMP3-expressing cells were frame scanned at 200Hz using the resonance
scanner of a Leica SP5 confocal microscope. Confocal software was used to
measure relative fluorescence intensity changes and kinetics of induced Ca2þ
transients.
Immunolabelling. Whole mount embryos were immunolabelled as described
previously26. For labelling dissociated skeletal muscle fibres, 48 hpf embryos were
incubated in collagenase type II (3.125mgml 1 in CO2-independent medium) at
20 C for 1.5 h with the muscle fibres triturated every 30min. Fibres were spun at
380 g for 5min, supernatant removed and fibres resuspended and allowed to settle
on polyornithine-coated coverslips. Fibres were washed then fixed. Dissociated
muscles were labelled using 0.25% detergent in the incubation solutions containing
the following primary antibodies/toxin: 1/200 dilution of anti-RyR (34C IgG1,
Sigma); 1/200 anti-DHPRa1 (1A IgG1, Affinity BioReagents); 1/10 bungarotoxin-
Alexa594 (Invitrogen); 1/500 anti-SV2; 1/200 anti-a actinin; and 1/200 anti-
dystrophin (all from Iowa Hybridoma Bank). In some cases nuclei were labelled


















































































Figure 8 | The stac3NAM allele decreases EC coupling. (a) Expression of Stac3NAM by muscle fibres in stac3mi34 embryos does not rescue touch-evoked
swimming. Superimposed frames (30Hz) showing that a heat-induced mutant embryo previously injected with pHSP70:stacNAM-egfp does not swim
following tactile stimulation (top), despite expression of zebrafish Stac3NAM-EGFP in myotomes and triadic localization of zebrafish Stac3NAM-EGFP
(middle, scale bars: 180 and 10mm). Histograms (bottom) quantify the comparable lack of touch-evoked swimming of stac3mi34 mutants expressing the
NAM allele (black) and uninjected mutants (grey) both 3 and 24 h post heat shock (hphs). Note the difference in scale of the y axis from that in Fig. 4a that
shows swimming in mutant rescued embryos. #Denotes zero movement. (b) Expression of Stac3NAM by muscle fibres in stac3mi34 embryos partially
rescues Ca2þ transients in vivo. Examples of stac3mi34 mutant slow and fast twitch fibres coexpressing a-actin-driven GCaMP3 and hsp70-regulated
zebrafish Stac3NAM-mCherry. The triadic localization of Stac3wt-mCherry cannot be seen due to the low resolution of the resonance scans used to detect
the fluorescent proteins. (c) Top, Ca2þ transients from mutant fast and slow fibres coexpressing Stac3NAM-mCherry and GCaMP3. Middle, histogram
showing that peak Ca2þ release is decreased between mutant fast fibres expressing stac3wt (grey, n¼6) and stac3NAM (white, n¼6). Peak Ca2þ was not
different for mutant slow twitch fibres (wt, n¼ 2; NAM allele, n¼ 2). Bottom, histogram showing the kinetics of Ca2þ transients of mutant fast fibres
expressing stac3wt (grey, n¼ 5) and stac3NAM (white, n¼ 9). Asterisk signifies Po0.01, t-test. Error bars represent s.e.m.’s.
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Positional cloning of stac3. To identify the gene mutated in stac3mi34 mutants,
the mutation was meiotically mapped to PCR-scorable, polymorphic CA repeats as
described previously45 by scoring 2009 mutant embryos derived from appropriate
mapping crosses. Flanking markers were identified located on linkage group 9;
z1830 that was 0.21 cM north of stac3mi34 and z1663 that was 1.24 cM south.
Analysis of the zebrafish genome database (http://www.sanger.ac.uk/resources/
zebrafish/) revealed that z1830 was located in a small contig of assembled sequence
(Scaffold 450) from the zV5 assembly of the sequenced genome that contained the
pcbp2 gene. A new marker (zh1) located in pcbp2 mapped 0.11 cM north of
stac3mi34. A sequenced 156-kb BAC (CR848672) that contained pcbp2 was
identified and analysed for potential genes with the gene prediction program,
GENSCAN (http://genes.mit.edu/GENSCAN.html), and BLASTing predicted
genes against the NCBI database (http://www.ncbi.nlm.nih.gov/BLAST). These
were pcbp2, kif5a, arp5 and a gene similar to stac. New markers, zh34 in kif5a
(0.04 cM north), zh16 in arp5 (0.04 cM south) and zh31 in the stac-like gene (no
recombinants), were identified. The stac-like cDNA from wt and mutant embryos
were isolated and sequenced, and the mutant cDNA contained an insertion that
included an in-frame stop codon. Analysis of genomic sequences determined that
the stac3mi34 allele contained a missense mutation that transformed a splice donor
site for the intron between exons 4 and 5 (GT to AT), which presumably lead to
incorrect splicing and inclusion of the intron in the cDNA.
Mutant rescue. Rescue of stac3mi34 behaviour was performed by subcloning
zebrafish stac3wt, stac3mi34, stac3NAM or human STAC3 into pHSP70-EGFP42.
Zebrafish stac3NAM construct was generated by site-directed mutagenesis.
Constructs (10 ng ml 1) were injected into one-cell stage progeny of stac3mi34
carriers with a Nanoject II. At 48 hpf, stac3mi34 mutant embryos were behaviourally
identified and heat induced by switching them from water at 28.5 C to 37 C for
1 h. After heat induction, embryos were switched back to 28.5 C and assayed 3 and
24 h later. Embryos with B10% or more skeletal muscle fibres expressing EGFP
were used for behavioural assays. Responses of embryos to touch were video
recorded and measured. For Ca2þ imaging of Stac3wt- or StacNAM-expressing
muscle fibres pHSP70:stac3wt-mCherry and pHSP70:stac3NAM-mCherry were
generated along with a-actin:GCaMP3. Embryos were injected with a 1:1 mixture
of a stac3 construct and a-actin:GCaMP3 each at 10 ng ml 1. After heat induction,
embryos with skeletal muscle fibres expressing both constructs were selected for
Ca2þ imaging.
Analysis of maternal transcripts by RT-PCR. The start of midblastula transition
and earliest zygotic transcription is at 3 hpf in zebrafish34. Fifty embryos at 2 and 3
hpf each were placed in Trizol, and RT-PCR was performed for stac3 and
tuba1 (tubulin a1), a house-keeping gene that is maternally expressed46. Exon-
overlapping primer pairs shown below were designed to amplify B200-bp
fragments of cDNA from the 50 (representing exons 3–6) or 30 (exons 4–10) region
of mature stac3 message. 50 Primer pair (forward: 50-GGACGACAACACTGTGT
ATTTTGTGTATG-30 ; reverse: 50-GAACCCAGGAGGTATTTTGCCGAAGCA
TCT-30); 30 primer pair (forward: 50-ACGGATGATTGTTCTCAATAATA
AGTTTGC-30 reverse: 50-CGCAACAGATGACAAGAACAAGAAGCAG-30).
Antisense MO knockdowns. 4.6 nl of 400mM solutions of translation-blocking
antisense MO (GeneTools) or standard control MO were injected into recently
fertilized embryos from crosses of stac3mi34 carriers using a Nanoject II. The
sequence of the antisense stac3 MO was: 50-TCATATTGAGCCATCAGTCCAGC-
30 with CAT corresponding the start ATG. For morphant rescue experiments,
10 ng ml 1 of a-actin:stac3-egfp was coinjected along with the antisense MOs.
Embryos were assayed for response to touch with forceps at 48 hpf and subse-
quently fixed and assayed with anti-Stac3.
Polyclonal antiserum production and purification. Full-length zebrafish Stac3
was expressed as a His–Sumo fusion protein in B21(DE3) cells (Invitrogen), and
affinity-purified using Ni-NTA agarose. Protein was further purified by electro-
phoresis in a NuPAGE 4–12% SDS–polyacrylamide gel electrophoresis (SDS–
PAGE) Bis-Tris Gel and subsequent excision of appropriate Coomassie-stained
band. Rabbits were immunized with gel slices of purified fusion proteins. Anti-
serum was purified by passing through a Sulfolink column (Thermo) containing
the immobilized fusion protein. Fragment of Stac3 that was bound by anti-Stac3
was identified as follows. Full-length stac3 cDNA and the fragment that encodes
amino acids 1–63 were cloned in frame into pGADGT7 (Clontech), which contains
an N-terminal HA tag and Gal4 activation domain. Each construct was trans-
formed into Y2HGold Yeast using Yeastmaker Yeast Transformation system 2
(Clontech) and plated on appropriate auxotrophic media. Yeast was grown,
collected and protein extracted with YPER yeast protein extraction reagent
(Thermo). Protein samples were loaded for SDS–PAGE analysis, blotted onto
nitrocellulose and probed separately with anti-HA or anti-Stac3.
Western analysis and immunoprecipitation. Fifty stac3mi34 mutant and sibling
embryos each were collected, lysed and the isolated protein loaded and separated
by SDS–PAGE22. Anti-DHPRa1 was used for immunoblotting at 1:500, anti-pan-
RyR at 1:2,000. Adult female fish were killed using 0.1% tricaine, skeletal muscle
dissected on dry ice and total protein extracted. Protein lysate from an individual
fish was immunoprecipitated using anti-DHPRa1 (1:100), or anti-pan-RyR (1:200)
cross-linked with BS3 (Thermo) to Protein G Dynabeads (Invitrogen).
Generation of stable transgenic line. a-Actin:stac3-gfp construct was injected at
20 ng ml 1 into the cytoplasm of embryos at the one-cell stage. Fish were raised to
adulthood and germline founders identified by screening F1 progeny for GFP
fluorescence. GFP-positive offspring were raised to establish the transgenic line.
Mass spectrometry and data analysis. Skeletal muscle lysates from 10 adult
a-actin:stac3-gfp transgenic fish were pooled for immunoprecipitation with anti-
GFP (Torrey Pines Biolabs Inc.) or normal mouse IgG. The pull-down fraction was
separated using SDS–PAGE, and the fractions in the gel stained using Silver Stain
Kit (Pierce). Thirteen bands appearing in the anti-GFP pull-down fraction lane but
not in normal IgG pull-down lane were excised, washed with 25mM ammonium
bicarbonate followed by acetonitrile, reduced with 10mM dithiothreitol at 60 C
followed by alkylation with 50mM iodoacetamide at room temperature, and
digested with trypsin at 37 C for 4 h. Mass spectrometry was performed by the
University of Michigan Proteomics and Peptide Synthesis Core using a nano LC/
MS/MS with a Waters NanoAcquity HPLC system interfaced to a ThermoFisher
LTQ Orbitrap Velos. Peptides were loaded on a trapping column and eluted over a
75-mm analytical column at 350 nlmin 1; both columns were packed with Jupiter
Proteo resin (Phenomenex). The mass spectrometer was operated in data-depen-
dent mode, with MS performed in the Orbitrap at 60,000 FWHM resolution and
MS/MS performed in the LTQ. The fifteen most abundant ions were selected
for MS/MS.
MS/MS samples were analysed using Mascot (Matrix Science, London). Mascot
was set up to search the ipi.DANRE.v3.75.decoy database (74,790 entries). Mascot
was searched with a fragment ion mass tolerance of 0.50Da and a parent ion
tolerance of 10.0 p.p.m. Carbamidomethyl of cysteine was specified in Mascot as a
fixed modification.
Scaffold (version Scaffold_3.1.2, Proteome Software Inc., Portland, OR) was
used to validate MS/MS-based peptide and protein identifications. Peptides were
identified at 495% probability and proteins were identified if they contained at
least two identified peptides with each peptide identified in the protein at 495%
probability. Peptide and protein probabilities were assigned by the Protein
Prophet algorithm47. Proteins that contained similar peptides and could not be
differentiated based on MS/MS analysis alone were grouped to satisfy the principles
of parsimony.
Molecular analysis of NAM. The cohort of individuals with NAM was previously
described34. NAM subjects were of Lumbee Indian descent with congenital
muscle weakness who demonstrate two or more of the following phenotypic
characteristics: myopathic facies, susceptibility to malignant hyperthermia,
kyphoscoliosis and cleft palate. The probands were ascertained from the University
of North Carolina at Chapel Hill Pediatric Genetics Clinic and from the Duke
University Muscular Dystrophy Clinic. All data and samples were collected
following informed consent of subjects; this study was approved by the Duke
University Medical Center and the University of North Carolina Institutional
Review Boards. DNA was extracted from whole blood using the Puregene system
(Gentra Systems, Minneapolis, MN) and stored in the laboratory of the Duke
Center for Human Genetics.
Initially, each exon and the surrounding splicing regions of STAC3 were
screened in three NAM patients and three related individuals through PCR
amplification and automated Sanger sequencing. After identification of the NAM
mutation in exon 10 of STAC3, the entire cohort of available samples from NAM
pedigrees was screened by exon amplification and sequencing for the mutation. In
all, a total of 18 individuals from five Lumbee families were sequenced, as well as
three unrelated unaffected Lumbee individuals. In addition, genomic DNA was
screened from two neurologically normal control individuals (Coriell Institute
NDPT006 and NDPT009) and from a collection of 111 adult subjects without
evidence of neurological disease48.
Electron microscopy. Transmission electron microscopy was performed as
previously described7,49. A minimum of three larvae per condition were examined.
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